Home
Douglas Kerr, Chief Medical Officer: Dyne Therapeutics DYN Sell · Filed 05/14
Trade details
- Type
- Insider sale
- Amount
- $28,715.04
- Shares · price
- 1,564 sh · $18.36 a share
- Held after
- 170,042 sh
- Trade date
- 26/05/13
- Filed
- 26/05/14
- Days to filing
- 1 days
Sold 0.9% of holdings
- Share of holding sold
- 0.9%
Dyne Therapeutics trades, last 26 weeks
What else happened in Dyne Therapeutics around then
Filed or reported within 30 days of the trade day · 04/13~06/12Douglas Kerr's recent trades
- Douglas Kerr
Planned saleDyne Therapeutics
Planned saleDyne Therapeutics
DYN
$661
35 sh
$661
Filed 09/08
Traded 09/08
- Douglas Kerr
Planned saleDyne Therapeutics
Planned saleDyne Therapeutics
DYN
$121.7K
5,000 sh
$121.7K
Filed 09/04
Traded 09/04
- Douglas Kerr
Planned saleDyne Therapeutics
Planned saleDyne Therapeutics
DYN
$64.2K
2,443 sh
$64.2K
Filed 08/13
Traded 08/13
- Douglas Kerr
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$16.3K
887 sh
$16.3K
Filed 06/17
Traded 06/16
- Douglas Kerr
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$13.5K
904 sh
$13.5K
Filed 03/06
Traded 03/05